Pfizer has signed a licensing agreement worth up to $6 billion with Chinese pharmaceutical products developer 3SBio Inc for ...

Eleven-year follow-up data continue to show the invasive disease-free survival benefit for node-positive patients seen in previous analyses.

Reproductive-rights advocates are pushing back against the review of the abortion medication mifepristone ordered by Health ...

Last week, readers were most interested in a story about Accelerate Diagnostics' issues leading up to its bankruptcy filing.